NCT05056389RecruitingPhase 1
Normothermic intraperitoneal chemotherapy – long term in peritoneal metastases from colorectal cancer – feasibility study
Source: EU CTIS (euclinicaltrials.eu) · Last updated 14 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 16 Oct 2024
- Start date
- 14 Nov 2024
- Lead sponsor
- Oslo University Hospital HF
- Diseases
- Colorectal cancer
- NCT number
- NCT05056389
- EU CT number
- 2023-510217-26-00
- EudraCT number
- 2020-004944-27
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 20
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oslo University Hospital HF Coordinator of this site? Confirm its status | Oslo | Norway | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.